Filter By:
Reporting
Reporting
Ongoing
CTN 281: EPIC 4 Study
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Learn MoreCompleted
CTN 043: Whey Protein Supplementation
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
Learn MoreCompleted
CTN 034: Erythropoietin deficiency in children
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
Learn MoreReporting
CTNPT 003: Bone and renal outcomes in tenofovir exposed infants
Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.